ShotelersukVTosukhowongPChotivitayatarakornPPongpunlertW.A Thai boy with hereditary enzymopenic methemoglobinemia type II. J Med Assoc Thai. 2000;83(11):1380-1386.
2.
FreyBKehrerB.Toxic methemoglobin concentrations in premature infants after application of a prilocaine-containing cream and peridural prilocaine. Eur J Pediatr. 1999;158(10):785-788. doi:10.1007/s004310051204.
3.
SolheimLBrunACGreibrokkTSJacobsenDFossumC.Methemoglobinemia: causes, diagnosis and treatment. Tidsskr Nor Laegeforen. 2000;120(13):1549-1551.
4.
GuptaVKulkarniAWarangPDevendraRChiddarwarAKedarP.Mutation update: variants of the CYB5R3 gene in recessive congenital methemoglobinemia. Hum Mutat. 2020;41(4):737-748. doi:10.1002/humu.23973.
5.
SiendonesEBallesterosMNavasP.Cellular and molecular mechanisms of recessive hereditary methemoglobinemia type II. J Clin Med. 2018;7(10):341. doi:10.3390/jcm7100341.
FermoEBianchiPVercellatiC, et al. Recessive hereditary methemoglobinemia: two novel mutations in the NADH-cytochrome b5 reductase gene. Blood Cells Mol Dis. 2008;41(1):50-55. doi:10.1016/j.bcmd.2008.02.002.
8.
YilmazDCoguluOOzkinayFKavaklıKRoosD.A novel mutation in the DIA1 gene in a patient with methemoglobinemia type II. Am J Med Genet. 2005;133A(1):101-102. doi:10.1002/ajmg.a.30467.
9.
EwenczykCLerouxARoubergueA, et al. Recessive hereditary methemoglobinemia, type II: delineation of the clinical spectrum. Brain. 2008;131(pt 3):760-761. doi:10.1093/brain/awm337.
10.
Hojas-BernalRMcNab-MartinPFairbanksVFHolmesMWHoyerJDMcCormickDJ.Hb Chile [beta28(B10)Leu→Met]: an unstable hemoglobinassociated with chronic methemoglobinemia and sulfonamide or methylene blue-induced hemolyticanemia. Hemoglobin. 1999;23(2):125-134. doi:10.3109/03630269908996157.
IalosconABianchiPAndolfoI, et al. Recommen-dations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021;96(12):1666-1678. doi:10.1002/ajh.26340.
